Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children

Are oral immunotherapy (OIT) treatments cost-effective for managing peanut allergy in children?This economic evaluation conducted alongside a clinical trial involving 201 children found that both probiotic peanut OIT (PPOIT) and peanut OIT were cost-effective compared with no treatment when remission was the effectiveness outcome. When effectiveness was assessed using quality-adjusted life years, PPOIT offered the best value.These findings suggest that PPOIT and OIT present good value compared with no treatment for achieving remission.

Corresponding Author: Kim Dalziel, PhD, Melbourne School of Population and Global Health, The University of Melbourne, 4/207 Bouverie St, Carlton, VIC 3053, Australia (kim.dalziel@unimelb.edu.au).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.